Theravance Biopharma, Inc.·4

Aug 24, 7:07 PM ET

WORBOYS PHILIP D 4

4 · Theravance Biopharma, Inc. · Filed Aug 24, 2021

Insider Transaction Report

Form 4
Period: 2021-08-20
WORBOYS PHILIP D
SVP, Translational Science
Transactions
  • Tax Payment

    Ordinary Shares

    2021-08-20$14.05/sh4,307$60,513335,062 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -